p.87 抽出テキスト

646. Winkle RA, Mead RH, Engel G, Kong MH, Fleming W, Salcedo J, et al. Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications. Heart Rhythm 2017;14:819–27. https://doi.org/10.1016/j.hrthm.2017.02.023 647. Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan G-A, et al. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). EP Europace 2015;17:1197–214. https://doi.org/10.1093/ europace/euv190 648. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol 2012;33:171–257. https://doi.org/10.1007/s10840-012-9672-7 649. Noubiap JJ, Agbaedeng TA, Ndoadoumgue AL, Nyaga UF, Kengne AP. Atrial thrombus detection on transoesophageal echocardiography in patients with atrial fibrillation undergoing cardioversion or catheter ablation: a pooled analysis of rates and predictors. J Cardiovasc Electrophysiol 2021;32:2179–88. https://doi.org/10.1111/jce.15082 650. Lurie A, Wang J, Hinnegan KJ, McIntyre WF, Belley-Côté EP, Amit G, et al. Prevalence of left atrial thrombus in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2021;77:2875–86. https://doi.org/10.1016/j.jacc.2021.04.036 651. Efremidis M, Bazoukis G, Vlachos K, Prappa E, Megarisiotou A, Dragasis S, et al. Safety of catheter ablation of atrial fibrillation without pre- or peri-procedural imaging for the detection of left atrial thrombus in the era of uninterrupted anticoagulation. J Arrhythm 2021;37:28–32. https://doi.org/10.1002/joa3.12466 652. Diab M, Wazni OM, Saliba WI, Tarakji KG, Ballout JA, Hutt E, et al. Ablation of atrial fibrillation without left atrial appendage imaging in patients treated with direct oral anticoagulants. Circ Arrhythm Electrophysiol 2020;13:e008301. https://doi.org/10.1161/ CIRCEP.119.008301 653. Patel K, Natale A, Yang R, Trivedi C, Romero J, Briceno D, et al. Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter registry. Heart Rhythm 2020;17:2093–9. https://doi.org/10.1016/j.hrthm.2020. 07.017 654. Mao YJ, Wang H, Huang PF. Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation. J Interv Card Electrophysiol 2021;60:407–17. https://doi.org/10.1007/s10840- 020-00754-6 655. van Vugt SPG, Westra SW, Volleberg R, Hannink G, Nakamura R, de Asmundis C, et al. Meta-analysis of controlled studies on minimally interrupted vs. continuous use of nonvitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation. Europace 2021;23:1961–9. https://doi.org/10.1093/europace/euab175 656. Ge Z, Faggioni M, Baber U, Sartori S, Sorrentino S, Farhan S, et al. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Cardiovasc Ther 2018;36:e12457. https:// doi.org/10.1111/1755-5922.12457 657. Asad ZUA, Akhtar KH, Jafry AH, Khan MH, Khan MS, Munir MB, et al. Uninterrupted versus interrupted direct oral anticoagulation for catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2021;32:1995–2004. https://doi.org/10.1111/jce.15043 658. Mao YJ, Wang H, Huang PF. Peri-procedural novel oral anticoagulants dosing strategy during atrial fibrillation ablation: a meta-analysis. Pacing Clin Electrophysiol 2020;43: 1104–14. https://doi.org/10.1111/pace.14040 659. Basu-Ray I, Khanra D, Kupó P, Bunch J, Theus SA, Mukherjee A, et al. Outcomes of uninterrupted vs interrupted periprocedural direct oral anticoagulants in atrial fibrillation ablation: a meta-analysis. J Arrhythm 2021;37:384–93. https://doi.org/10.1002/joa3. 12507 660. Romero J, Cerrud-Rodriguez RC, Diaz JC, Rodriguez D, Arshad S, Alviz I, et al. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2019;30:1250–7. https://doi.org/10.1111/jce. 14052 661. Liu XH, Xu Q, Luo T, Zhang L, Liu HJ. Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: a systematic review and meta-analysis of prospective studies. PLoS One 2021;16:e0253709. https://doi.org/10.1371/journal.pone. 0253709 662. Proietti R, AlTurki A, Di Biase L, China P, Forleo G, Corrado A, et al. Anticoagulation after catheter ablation of atrial fibrillation: an unnecessary evil? A systematic review and meta-analysis. J Cardiovasc Electrophysiol 2019;30:468–78. https://doi.org/10.1111/jce. 13822 663. Maduray K, Moneruzzaman M, Changwe GJ, Zhong J. Benefits and risks associated with long-term oral anticoagulation after successful atrial fibrillation catheter ablation: systematic review and meta-analysis. Clin Appl Thromb Hemost 2022;28:1076029622 1118480. https://doi.org/10.1177/10760296221118480 664. Brockmeyer M, Lin Y, Parco C, Karathanos A, Krieger T, Schulze V, et al. Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials. Acta Cardiol 2021;76:288–95. https://doi.org/10.1080/00015385.2020.1724689 665. Di Monaco A, Guida P, Vitulano N, Quadrini F, Troisi F, Langialonga T, et al. Catheter ablation of atrial fibrillation with uninterrupted anticoagulation: a meta-analysis of six randomized controlled trials. J Cardiovasc Med (Hagerstown) 2020;21:483–90. https:// doi.org/10.2459/JCM.0000000000000939 666. Maesen B, Luermans J, Bidar E, Chaldoupi SM, Gelsomino S, Maessen JG, et al. A hybrid approach to complex arrhythmias. Europace 2021;23:ii28–33. https://doi.org/10.1093/ europace/euab027 667. van der Heijden CAJ, Vroomen M, Luermans JG, Vos R, Crijns H, Gelsomino S, et al. Hybrid versus catheter ablation in patients with persistent and longstanding persistent atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2019;56: 433–43. https://doi.org/10.1093/ejcts/ezy475 668. Boersma LV, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation 2012;125:23–30. https://doi.org/10.1161/ CIRCULATIONAHA.111.074047 669. Castella M, Kotecha D, van Laar C, Wintgens L, Castillo Y, Kelder J, et al. Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial. Europace 2019;21:746–53. https://doi.org/10.1093/europace/ euy325 670. van der Heijden CAJ, Weberndörfer V, Vroomen M, Luermans JG, Chaldoupi SM, Bidar E, et al. Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: a randomized controlled trial. JACC Clin Electrophysiol 2023;9:1013–23. https:// doi.org/10.1016/j.jacep.2022.12.011 671. DeLurgio DB, Crossen KJ, Gill J, Blauth C, Oza SR, Magnano AR, et al. Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation: results of CONVERGE clinical trial. Circ Arrhythm Electrophysiol 2020;13: e009288. https://doi.org/10.1161/CIRCEP.120.009288 672. Pokushalov E, Romanov A, Elesin D, Bogachev-Prokophiev A, Losik D, Bairamova S, et al. Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial. J Cardiovasc Electrophysiol 2013; 24:1338–43. https://doi.org/10.1111/jce.12245 673. Haldar S, Khan HR, Boyalla V, Kralj-Hans I, Jones S, Lord J, et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J 2020;41:4471–80. https://doi.org/10.1093/ eurheartj/ehaa658 674. Doll N, Weimar T, Kosior DA, Bulava A, Mokracek A, Mönnig G, et al. Efficacy and safety of hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation: a randomised, controlled trial. EClinicalMedicine 2023;61:102052. https://doi.org/10.1016/j.eclinm.2023. 102052 675. Malaisrie SC, McCarthy PM, Kruse J, Matsouaka R, Andrei AC, Grau-Sepulveda MV, et al. Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2018;155:2358–2367 e1. https://doi.org/10. 1016/j.jtcvs.2018.01.069 676. Saxena A, Dinh DT, Reid CM, Smith JA, Shardey GC, Newcomb AE. Does preoperative atrial fibrillation portend a poorer prognosis in patients undergoing isolated aortic valve replacement? A multicentre Australian study. Can J Cardiol 2013;29:697–703. https://doi.org/10.1016/j.cjca.2012.08.016 677. Quader MA, McCarthy PM, Gillinov AM, Alster JM, Cosgrove DM, 3rd, Lytle BW, et al. Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg 2004;77:1514–22; discussion 1522–4. https://doi.org/10.1016/j. athoracsur.2003.09.069 678. Damiano RJ, Jr, Schwartz FH, Bailey MS, Maniar HS, Munfakh NA, Moon MR, et al. The Cox Maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg 2011; 141:113–21. https://doi.org/10.1016/j.jtcvs.2010.08.067 679. Cox JL, Schuessler RB, Boineau JP. The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000;12:2–14. https:// doi.org/10.1016/S1043-0679(00)70010-4 680. Melby SJ, Zierer A, Bailey MS, Cox JL, Lawton JS, Munfakh N, et al. A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg 2006;244:583–92. https://doi.org/10.1097/01.sla. 0000237654.00841.26 681. Badhwar V, Rankin JS, Damiano RJ, Jr, Gillinov AM, Bakaeen FG, Edgerton JR, et al. The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg 2017;103:329–41. https://doi.org/10.1016/ j.athoracsur.2016.10.076 682. Ad N, Henry L, Hunt S, Holmes SD. Impact of clinical presentation and surgeon experience on the decision to perform surgical ablation. Ann Thorac Surg 2013;96:763–8; discussion 768–9. https://doi.org/10.1016/j.athoracsur.2013.03.066 683. Cheng DC, Ad N, Martin J, Berglin EE, Chang BC, Doukas G, et al. Surgical ablation for atrial fibrillation in cardiac surgery: a meta-analysis and systematic review. Innovations (Phila) 2010;5:84–96. https://doi.org/10.1177/155698451000500204 Downloaded from academic.oup.com/eurheartj/article/45/36/3314/7738779 by guest on 07 October 2026